P. Poliani

发表

Caspase-1 regulates the inflammatory process leading to autoimmune demyelination.

M. Su, G. Comi, R. Flavell, 1999, Journal of immunology.

CEACAM1/VEGF cross‐talk during neuroblastic tumour differentiation

M. Memo, C. Wagener, P. L. Poliani, 2007, The Journal of pathology.

Development of an HSV-Based Vector for the Treatment of Parkinson's Disease

J. Glorioso, W. Goins, D. Fink, 1997, Experimental Neurology.

Engineering Herpes Simplex

R. Ramakrishnan, Martin C. Schmidt, J. Glorioso, 1997 .

Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice

G. Comi, G. Martino, F. Ruffini, 2001, Gene Therapy.

Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis.

M. Rovaris, G. Comi, G. Martino, 2001, Human gene therapy.

Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination.

G. Comi, L. Grimaldi, G. Martino, 1998, Human gene therapy.

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

R. Ramakrishnan, P. L. Poliani, J. Glorioso, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Deletion of the S component inverted repeat sequence c' and the nonessential genes U(S)1 through U(S)5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system.

J. Glorioso, P. Poliani, D. Fink, 1997, Journal of neurovirology.

Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR

R. Ramakrishnan, J. Glorioso, D. Fink, 1996, Journal of virology.

Engineering herpes simplex virus vectors for human gene therapy.

R. Ramakrishnan, J. Glorioso, W. Goins, 1997, Advances in pharmacology.

The role of proinflammatory cytokines in multiple sclerosis

G. Martino, R. Furlan, A. Bergami, 1999 .

Immunophenotypic and genotypic analysis of a case of primary peripheral primitive neuroectodermal tumour (pPNET) of the urinary bladder

S. Pilotti, M. Colecchia, G. Dagrada, 2002, Histopathology.

Drug inducible transgene expression in brain using a herpes simplex virus vector

J. Glorioso, T. Oligino, J. Glorioso, 1998, Gene Therapy.

Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing–remitting autoimmune encephalomyelitis in Biozzi AB/H mice

G. Comi, G. Martino, F. Ruffini, 2001, Gene Therapy.

Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors

G. Comi, G. Martino, R. Furlan, 2000, Gene Therapy.

Cytokines and immunity in multiple sclerosis: the dual signal hypothesis

G. Comi, L. Grimaldi, G. Martino, 2000, Journal of Neuroimmunology.

Inflammation and Multiple Sclerosis: a Close Interplay

G. Martino, R. Furlan, P. Poliani, 1999 .

A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines

G. Comi, L. Grimaldi, G. Martino, 1998, Multiple sclerosis.

Herpes simplex virus vectors for gene transfer to the nervous system.

R. Ramakrishnan, J. Glorioso, W. Goins, 1997, Journal of neurovirology.

In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16.

M. Schmidt, J. Glorioso, P. Marconi, 1996, Gene therapy.